AI assistant
Sending…
Alligator Bioscience — Major Shareholding Notification 2024
Apr 25, 2024
3138_iss_2024-04-25_dc856950-3cdb-4043-adb7-820a4852c690.pdf
Major Shareholding Notification
Open in viewerOpens in your device viewer
{# SEO P0-1: filing HTML is rendered server-side so Googlebot
sees the full text without executing JS or following an
iframe to a Disallow'd CDN path. The content has already
been sanitized through filings.seo.sanitize_filing_html. #}

Issuer Alligator Bioscience AB
Holder
Avanza Bank Holding AB för Försäkringsaktiebolaget Avanza Pension
| Instrument | |
|---|---|
| Instrument | Aktier |
| Before the transaction | |
| Shares | Data not given* |
| Voting rights | Data not given* |
| Transaction | |
| Reason for major shareholding notification New share issue | |
| Date | 24/04/2024 |
| Limit for number of shares | 5 % |
| Limit for number of votes | 5 % |
| After the transaction | |
| Quantity | |
| Shares | 37,530,894 |
| Directly held voting rights | 0 |
| Indirectly held voting rights | 37,530,894 |
| Percentage | |
| Directly held shares | 4.94485 % |
| Directly held voting rights | 0 % |
| Indirectly held voting rights | 4.95043 % |
Resulting distribution of total holdings
| Percentage of voting rights: |
Number of underlying shares: |
|
|---|---|---|
| Shares | 4.95043 % | 37,530,894 |
| Instruments - FITA Ch. 4, section 2, first paragraph, line 2 |
||
| Instruments - FITA Ch. 4, section 2, first paragraph, line 3 |
||
| - Physically settled | ||
| - Cash settled | ||
| Total | 4.95043 % | 37,530,894 |
| Group total holdings |
Voting rights 37,530,894 Percentage of voting rights 4.95043
Notes (other relevant informations according to law)
Aktierna innehas av Försäkringsaktiebolaget Avanza Pension som är ett helägt dotterbolag till Avanza Bank Holding AB (publ). Det är försäkringskunder som via depåfullmakt innehar de aktuella aktierna. Innehavet är beräknat på 758 989 086 utestående aktier och 758 134 221 röster.
Published
25/04/2024 13:13
Contact
Name Marie Karlsfeldt
Email [email protected]
*Source of information has chosen not to submit the data

[email protected] Tfn 08-408 980 37 Fax 08-24 39 25
More from Alligator Bioscience
Regulatory Filings
2026
May 6
Regulatory Filings
2026
May 6
Quarterly Report
2026
May 5
Quarterly Report
2026
May 5
Share Issue/Capital Change
2026
Mar 31
Share Issue/Capital Change
2026
Mar 31
Proxy Solicitation & Information Statement
2026
Mar 30
Proxy Solicitation & Information Statement
2026
Mar 30
Board/Management Information
2026
Mar 27
Board/Management Information
2026
Mar 27